|
|
Jaap Twisk, Donald L. Gillian-Daniel, Angie Tebon, Lin Wang, P. Hugh R. Barrett, Alan D. Attie
J Clin Invest. 2000;
105(4):521
doi:10.1172/JCI8623
Abstract |
Full text
| PDF
| Supplemental material

F
amilial hypercholesterolemia is caused by mutations in the LDL receptor gene (Ldlr). Elevated plasma LDL levels result from slower LDL catabolism and a paradoxical lipoprotein overproduction. We explored the relationship between the presence of the LDL receptor and lipoprotein secretion in hepatocytes from both wild-type and LDL receptor–deficient mice. Ldlr–/– hepatocytes secreted apoB100 at a 3.5-fold higher rate than did wild-type hepatocytes. ApoB mRNA abundance, initial apoB synthetic rate, and abundance of the microsomal triglyceride transfer protein 97-kDa subunit did not differ between wild-type and Ldlr–/– cells. Pulse-chase analysis and multicompartmental modeling revealed that in wild-type hepatocytes, approximately 55% of newly synthesized apoB100 was degraded. However, in Ldlr–/– cells, less than 20% of apoB was degraded. In wild-type hepatocytes, approximately equal amounts of LDL receptor–dependent apoB100 degradation occured via reuptake and presecretory mechanisms. Adenovirus-mediated overexpression of the LDL receptor in Ldlr–/– cells resulted in degradation of approximately 90% of newly synthesized apoB100. These studies show that the LDL receptor alters the proportion of apoB that escapes co- or post-translational presecretory degradation and mediates the reuptake of newly secreted apoB-containing lipoprotein particles.
Citation information
This citation data is accumulated from CrossRef, which receives citation information from participating publishers, including this journal.
Not all publishers participate in CrossRef, so this information is not comprehensive.
Additionally, data may not reflect the most current citations to this article,
and the data may differ from citation information available from other sources
(for example, Google Scholar, Web of Science, and Scopus).
Total citations by year
in CrossRef
Citations to this article
in CrossRef
(39)
| Title and authors |
Publication |
Year |
Hepatic autophagy mediates endoplasmic reticulum stress-induced degradation of misfolded apolipoprotein B
Wei Qiu, Jing Zhang, Mark J. Dekker, Huajin Wang, Ju Huang, John H. Brumell, Khosrow Adeli
|
Hepatology
|
2011 |
Advances in Clinical Chemistry
Patrizia Tarugi, Maurizio Averna
|
Advances in Clinical Chemistry Volume 54
|
2011 |
Postprandial lipoprotein metabolism in familial hypercholesterolemia: thinking outside the box
Dick C. Chan, Gerald F. Watts
|
Metabolism
|
2011 |
Phosphatidylcholine biosynthesis and lipoprotein metabolism
Laura K. Cole, Jean E. Vance, Dennis E. Vance
|
Biochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids
|
2011 |
Hepatic ABCA1 and VLDL triglyceride production
Mingxia Liu, Soonkyu Chung, Gregory S. Shelness, John S. Parks
|
Biochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids
|
2011 |
Genetic determinants of apolipoprotein B-100 kinetics
Theodore WK Ng, Esther MM Ooi, Gerald F Watts, Dick C Chan, P Hugh R Barrett
|
Current Opinion in Lipidology
|
2010 |
Apolipoprotein B100 secretion by cultured ARPE-19 cells is modulated by alteration of cholesterol levels
Tinghuai Wu, Masashi Fujihara, Jane Tian, Miroslava Jovanovic, Celene Grayson, Marisol Cano, Peter Gehlbach, Philippe Margaron, James T. Handa
|
Journal of Neurochemistry
|
2010 |
Hepatic insulin signaling regulates VLDL secretion and atherogenesis in mice
Seongah Han, Chien-Ping Liang, Marit Westerterp, Takafumi Senokuchi, Carrie L. Welch, Qizhi Wang, Michihiro Matsumoto, Domenico Accili, Alan R. Tall
|
J. Clin. Invest.
|
2009 |
Parameter Estimation for Linear Compartmental Models—A Sensitivity Analysis Approach
Barbara Juillet, Cécile Bos, Claire Gaudichon, Daniel Tomé, Hélène Fouillet
|
Ann Biomed Eng
|
2009 |
Cellular cholesterol trafficking and compartmentalization
Elina Ikonen
|
Nat Rev Mol Cell Biol
|
2008 |
|